Gerald van Belle1, Spyros D Mentzelopoulos2, Tom Aufderheide3, Susanne May1, Graham Nichol4. 1. Clinical Trial Center, Department of Biostatistics, University of Washington, Seattle, WA, USA. 2. University of Athens Medical School, Athens, Greece. 3. Medical College of Wisconsin, Milwaukee, WI, USA. 4. Clinical Trial Center, Department of Biostatistics, University of Washington, Seattle, WA, USA; University of Washington-Harborview Center for Prehospital Emergency Care, Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: nichol@uw.edu.
Abstract
BACKGROUND: Research in an emergency setting such as that with an acute cardiovascular event is challenging because the window of opportunity to treat may be short and may preclude time to obtain informed consent from the patient or their representative. Some perceive that requiring informed consent in emergency situations has limited improvements in care. Vulnerable populations including minorities or residents of low-income countries are at greatest risk of need for resuscitation. Lack of enrollment of such patients would increase uncertainties in treatment benefit or harm in those at greater risk of need for resuscitation. We sought to assess international variation in policies and procedures related to exception from informed consent (EFIC) or deferred consent for emergency research. METHODS: A brief survey instrument was developed and modified by consensus among the investigators. Included were multiple choice and open-ended responses. The survey included an illustrative example of a hypothetical randomized study. Elicited information included the possibility of conducting such a study in the respondent's country, as well as approvals required to conduct the study. The population of interest was emergency physicians or other practitioners of acute cardiovascular event research. RESULTS: Usable responses were obtained from 44 countries (76% of surveyed). Community opposition to EFIC was noted in 6 (14%) countries. Emergency Medical Services (EMS) providers in 8 (20%) countries were judged unable or unwilling to participate. A majority of countries (36, 82%) required approval by a Research Ethics Committee or similar. Government approval was required in 25 (57%) countries. CONCLUSION: There is international variation in practices and policies related to consent for emergency research. There is an ongoing need to converge regulations based on the usefulness of multinational emergency research to benefit both affluent and disadvantaged populations.
BACKGROUND: Research in an emergency setting such as that with an acute cardiovascular event is challenging because the window of opportunity to treat may be short and may preclude time to obtain informed consent from the patient or their representative. Some perceive that requiring informed consent in emergency situations has limited improvements in care. Vulnerable populations including minorities or residents of low-income countries are at greatest risk of need for resuscitation. Lack of enrollment of such patients would increase uncertainties in treatment benefit or harm in those at greater risk of need for resuscitation. We sought to assess international variation in policies and procedures related to exception from informed consent (EFIC) or deferred consent for emergency research. METHODS: A brief survey instrument was developed and modified by consensus among the investigators. Included were multiple choice and open-ended responses. The survey included an illustrative example of a hypothetical randomized study. Elicited information included the possibility of conducting such a study in the respondent's country, as well as approvals required to conduct the study. The population of interest was emergency physicians or other practitioners of acute cardiovascular event research. RESULTS: Usable responses were obtained from 44 countries (76% of surveyed). Community opposition to EFIC was noted in 6 (14%) countries. Emergency Medical Services (EMS) providers in 8 (20%) countries were judged unable or unwilling to participate. A majority of countries (36, 82%) required approval by a Research Ethics Committee or similar. Government approval was required in 25 (57%) countries. CONCLUSION: There is international variation in practices and policies related to consent for emergency research. There is an ongoing need to converge regulations based on the usefulness of multinational emergency research to benefit both affluent and disadvantaged populations.
Authors: Jerry P Nolan; Robert A Berg; Clifton W Callaway; Laurie J Morrison; Vinay Nadkarni; Gavin D Perkins; Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar; Kjetil Sunde; Alain Cariou Journal: Intensive Care Med Date: 2018-06-02 Impact factor: 17.440
Authors: Louisa W Whitesides; Jill M Baren; Michelle H Biros; Ross J Fleischman; Prasanthi R Govindarajan; Elizabeth B Jones; Arthur M Pancioli; Rebecca D Pentz; Victoria M Scicluna; David W Wright; Neal W Dickert Journal: Clin Trials Date: 2016-11-15 Impact factor: 2.486
Authors: Joseph Millum; Blythe Beecroft; Timothy Craig Hardcastle; Jon Mark Hirshon; Adnan A Hyder; Jennifer A Newberry; Carla Saenz Journal: BMJ Glob Health Date: 2019-07-29
Authors: Neal W Dickert; Victoria M Scicluna; Opeolu Adeoye; Dominick J Angiolillo; James C Blankenship; Chandan M Devireddy; Michael R Frankel; Sara F Goldkind; Gautam Kumar; Yi-An Ko; Andrea R Mitchell; Raul G Nogueria; Ruth M Parker; Manesh R Patel; Michele Riedford; Robert Silbergleit; Candace D Speight; Ilana Spokoyny; Kevin P Weinfurt; Rebecca D Pentz Journal: J Am Heart Assoc Date: 2019-01-22 Impact factor: 5.501
Authors: Lars W Andersen; Birthe Sindberg; Mathias Holmberg; Dan Isbye; Jesper Kjærgaard; Stine T Zwisler; Søren Darling; Jacob Moesgaard Larsen; Bodil S Rasmussen; Bo Løfgren; Kasper Glerup Lauridsen; Kim B Pælestik; Christoffer Sølling; Anders G Kjærgaard; Dorte Due-Rasmussen; Fredrik Folke; Mette Gitz Charlot; Kasper Iversen; Martin Schultz; Sebastian Wiberg; Rikke Malene H G Jepsen; Tobias Kurth; Michael Donnino; Hans Kirkegaard; Asger Granfeldt Journal: Resusc Plus Date: 2021-01-30